The 5, 6, 7 trimethoxy (1, 4) benzoxazine -2,3diones was synthesized by reaction of 2-amino-3,4,5 trimethoxyphenol with oxalyl chloride. The new compound of benzoxazine derivative was characterized by elemental analysis, mass spectroscopy , infrared and 1H-NMR . The compound exhibited antifungal and antibacterial activities.
Introduction
I. INTRODUCTION
In recent years benzoxazine derivatives containing nitrogen have attracted increased attention due to the broad spectrum of their biological activities {1} like antibacterial {2,3}antifungal {4}
Benzoxazines show a wide range of biological activity which are key molecules for the synthesis of various pharmaceutical agents as antifungal [5], antimicrobial [6]. There are only few reports suggesting the antimicrobial properties of benzoxazine derivatives so for [7,8]. Benzoxazine derivatives also display various biological activities such as anticancer [9], antimicrobial [10], antifungi [11], antiplatelet [12], and antituberculosis activities [13].
II. EXPERIMENTAL PART
A. Instrumentation
All melting points were measured on a Gallenkamp melting apparatus and uncorrted.The IR spectra of compounds were recorded on shimadzu IR Affinity FTIR spectrophotometer using KBr discs and the values are expressed in???? cm-1. The 1H-NMR spectra of compound were recorded on Bruker Avance 400 MHz NMR spectrophotometer using DMSO as an internal standard and the values are expressed in ???? ppm. The elemental analyasis of the compounds were recorded on a perkin – Elmer 2400 CHN elemental analyzer.
The mass spectra were recorded on a GCMS-QP-1000EX mass spectrometer at (70ev) Synthesis of 5, 6, 7 trimethoxy {1, 4} benzoxazine -2, 3 diones: In around bottom flask 250ml dissolve (16,3gm,0.1mole) of 2-amino-3,4,5 trimethoxyphenol in 100ml ethanol then add (12,6gm,0.1mole) of oxalyl chloride, stirr the mixture at room temperature for 2hrs then add 2ml of piperidine. The mixture was heated to reflux for 10hrs and keep overnight. The solide was separated by filtration. The solid was recrystallized from ethanol.
2, 3 diones : The infrared spectrum of table (2) displayed a strong band at 1665cm-1 corresponding to ? (C=O) (lactone),as well as the IR spectrum exhibited absorption band at 3218cm-1 due to (N- H). the 1H-NMR spectrum of the (2) in deuterated DMSO-d6 table (2)exhibited from low field to high field, the following signals (???? /ppm): 8,13(S,H,NH),7,65(S,1H,Ar- H)and 3,81(3S,9H,3OCH3). The mass spectrum of compound (1) exhibited the molecular ion peak [M]+ at m/e 253 (67%) indicating the molecular formula C11H11NO6, beside other fragemnts which are in accordance with the proposed structure 238(44%), 223(45%), 193(71%),163(80%),149(93%).77(100%).
A. Biological Activity
Measurement of antimicrobial activity using diffusion disc method: Antibacterial and antifungal activities of some synthesized compound was screened using the disc diffusion method. All the tested compounds showed antibacterial and antifungal activity and these activities were compared to standard amoxicillin, the results of antimicrobial studies are given in table 3, the antimicrobial activity of newly synthesized benzoxazine was conducted against gram positive and gram negative groups namely staphylococcus aureus and Escherichia coli respectively as well as Aspergillus flavus and candida albicans as tested fungi by disc diffusion method. Amoxicillin was employed as reference standard to compare the results. Each test compare was dissolved in dimethyl sulphoxide (DMSO). The concentration of DMSO solutions was 0.1 mg/ml.
Table 1: Physical characterization of benzoxazine derivative
M.P/C?color
Solvent yield
MF(M.wt)
Elemental analysis calc/found
C%
H%
N%
S%
184-186
Ethanol
C11H11NO6
52,17
4,37
5,53
Brown
90
253,208
51,82
3,95
4,79
Table 2: Spectroscopic for benzoxazine derivative
Compound No.
IR(KBr) ?cm-1
1HNMR????(PPm)
MS,Mm/z (%) relevan
(1)
?N-H3218
?C=O1665(Lacton)
8,13(S, H, NH)
7,65(S,1H, Ar-H)
3,81(3S,9H,3OCH3)
378(86,24%),359(32,19%)
352(49,23%),348(65,36%),332(54,10%),
266(83,29%),251(72,14%), 128(100%), 78(44,07%)
Table 3: The inhibition zone diameter of some benzoxazine derivative
Sample/ standard
Inhibition zone diameter (mm/mg sample)
Staphylococcus aureus (G+)
Escherichia coli (G-)
Candida albicans (fungus)
Aspergillus
benzoxazine
17
20
16
12
Amoxicillin
30
32
24
21
References
[1] Hossain M, Nada AK.Areview on Hetetocy synthesis and their application in medicinal chemist of imilazole moiety,science jornal of chemistry 2018;6(5):83-94.
[2] Azab ME,Youssef MM, ELBodaany EA.Synthesis and Antibacterial Evaluation of Novel Heterocyclic compounds containing a sulfonamido . Moiety, Molecules.2013;18:832-844.
[3] Martins P,Jesus J ,Santos S, Raposo LR ,Roma-Rodrigues C, Baptista PV , Fernandes AR. Heterocyclic Anticancer Compounds ; Recent Advances and the paradigm Shift towards the Use of nanomedicines Tool Box , Molecules, (2015) ;20:16852-16891.
[4] George M,Joseph L, Sadanandan HR. A Research on Synthesis of Oxazine Derivatives & Screening of Oxazine Derivatives for certain pharmacological Activies , I NTERNATIONAL Jornal of pharmacy & pharmaceutical Research , 2016;3:14-42.
[5] Fringuelli R, Pietrella D, Schiaffella F, Guarraci A, Perito S, Bistonib F, et al. Anti Candida albicans properties of novel benzoxazine analogues, Bioorg. Med. Chem. 2002; 10:1681-1686.
[6] Alper-Hayta S, Aki-Sener E, Tekiner-Gulbas B, Yildiz I, Temiz-Arpaci O, Yalcin I, et al. Synthesis, antimicrobialactivity and QSARs of new benzoxazine-3- one, Eur. J Med.Chem. 2006; 41:1398-1404.
[7] Sun Y, Niu C, Wang H, Zhang B, Xie F, Xu H, et al. Discovery of 3-benzoxazine-2,4 dione analogues as allosteric mitogen activated kinase (MEK) inhibitirs and antientervirus 71(EV71) agents, bioorg. Med. Chem. 2016; 24:3472-3482.
[8] IIoni G, Vasam S, Guguloth V, Vadde R. One-pot multicomponent systhsis of [1,4] benzoxazine isoxazole hybrids and their antibacterial activity, IJPCBS. 2018; 8:118-124
[9] Rajitha C, Dubey PK, Sunku V, Piedrafita FJ, Veeramaneni VR. Pal M, et al. Eur. J Med Chem. 2011; 46(10):4887-4896.
[10] Alper–Hayta S, Aki-Sener E, Tekiner – Gulbas B, Yildiz I, temiz-Arpaci O, Yalcin I, Altanlar N, et al. Eur J Med. Chem. 2006; 41(12):1398-1404.
[11] Shalaby AA, Elkhamry AM, Shiba SA, Ahmed AA, Hanafi AA, Arch. Pham. 2000; 333(11):365-372.
[12] Ihmaid SK, AlRawi JM, Bradley CJ, Angove MJ, Robrtson MN, Eur. J Med Chem, 2012; 57:85-101.
[13] Nemecek P, Mocak J, Lehotay J, Waisser K. Chem. Pep. 2013; 67(3):305-312.